Beckman Coulter’s new Access AccuTnI+3 troponin I assay has received FDA clearance for its UniCel DxI series of immunoassay systems at the same time as having a new CE Mark approved on the UniCel DxI and Access 2 immunoassay instruments.
Somatom Force – the new computer tomograph (CT) from Siemens – recently had its first public presentation worldwide at the University Medical Centre Mannheim, Germany.
The CMEF autumn show turned out to attract crowds from China, East and Central Asia, Africa, Europe, the U.S., and further regions.
Scientists at Imperial College in London, United Kingdom, have developed an ‘intelligent knife’ that instantly informs surgeons whether the tissue they are operating on is cancerous.
Crowds of hospital delegates flocking in to Xiamen on the first day of CMEF had already suggested that the event will be welcoming more than the roughly 60,000 delegates expected to participate
Although traditionally exporting timber and machinery, today Finland has established itself as a producer of high-tech products. This includes innovative medical technology.
The development of this tradeshow embodies the transformation China has gone through during the past decades: from its inception in 1979, CMEF – the China International Medical Equipment Fair – has developed into the largest event for the medical technology and IVD sectors in China and indeed in the Far East.
Already popular in private healthcare, increasing global acceptance of refurbished equipment encourages uptake in the public sector.
Professor Axel Haverich and team at the Clinic for Cardiothoracic, Transplant and Vascular Surgery in Hanover Medical School (MHH) have been carrying out research into decellularised heart valves for over 15 years. They trialled a procedure – initially in the laboratory and in animal experiments – which does not cause tissue rejection, is hoped to last a lifetime and, in the case of children,…
The healthcare sector is still booming in China: improved access to care remains high on the agenda of the Chinese national government, attracting domestic and international offerings.
Double-digit growth in Asia-Pacific and emerging markets to offset stagnation in US and Europe.
Plenary session endorsed essential measures that strengthen patient safety and improved the approaches on the approval system. The vote still leaves significant questions regarding the safety level for re-processing of medical devices.
Infusion solutions on the basis of HES (hydroxyethyl starch) are blood volume substitutes. They replace missing blood volume in patients with high blood loss, they stabilize the blood circulation and restore oxygen and nutrient supply to organs.
Telemedicine Clinic, Europe’s leading teleradiology company, has launched the TMC Radiology Quality Award, a €10,000 prize to promote quality initiatives within European radiology.
Medical technologies have maintained a leading position in European patent registrations for 15 years.
Eucomed, the European medical technology industry association, expresses disappointment and strong concern at the outcome of a vote in the European Parliament’s Committee for Environment, Public Health and Food Safety (ENVI).
The results of a survey amongst medical device companies in Europe about the financial impact of the upcoming changes in the European medical device regulation show a significant increase in costs for bringing new devices to patients.
A joint meeting combining the Euroson and Three Countries congresses creates a veritable European summit on the state-of-the-art in ultrasound
The new Hospital Engineering Lab in Duisburg, Germany, which was officially opened in July by Barbara Steffens, Health Minister for the German federal state, is a project of four Fraunhofer Institutes.
In 1839 Richard Thoma was the first to observe that arteries respond to flow: he identified a fundamental relationship between blood flow and arterial calibre.
A new procedure may help people with persistent hypertension. By burning or ablating the nerves in the renal arteries, blood pressure levels can be reduced significantly.
Ultrasound expands its role in cardiac imaging with disruptive applications. Fasten your seat belt. Cardiac diagnostics is entering a zone of turbulence. Manufacturers of leading systems continue to mine data from the sonic signal that opens new fields for research. John Brosky reports
Cardiologists believe they can restore coronary arteries thanks to a new generation of stents that help the body to strengthen collapsed vessels. Elsewhere, patients’ own stem cells are being programmed to rebuild cardiac muscle in HF patients.
Nothing new has been invented in heart failure in the last 15 years, according to Christian Homsy, CEO of Belgian-based Cardio3 Biosciences. This explains the excitement surrounding an emerging treatment among cardiologists, patients and investors.
The Catharina Hospital (Eindhoven, the Netherlands) and Royal Philips (NYSE: PHG, AEX: PHIA) today announced the results of a clinical study involving the treatment of 136 patients with complex heart rhythm disorders such as atrial fibrillation (AF).